Skip to content

Effect of acupoint stimulation on visual cortex function in participants with strabismus

Effect of acupoint stimulation on visual cortex function in participants with strabismus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102939
Enrollment
Unknown
Registered
2025-05-21
Start date
2024-11-30
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strabismus in children and adolescents

Interventions

Orthophoric group:None
Nonconcomitant strabismus:None
Concomitant strabismus with transcutaneous electrical acupoint stimulation group:Transcutaneous electrical acupoint stimulation
Non-concomitant strabismus with transcutaneous electrical acupoint stimulation group:Transcutaneous electrical acupoint stimulation

Sponsors

Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Orthotopic subjects: 1. Age between 6-12 years old, male or female, eye position is positive; 2. Binocular uncorrected visual acuity of children aged 6 to 7 years old >=0.7; Or children over 8 years old >=0.8; 3. The spherical equivalent (SE) was > -0.50D and =0.7 for children aged 6-7 years; Or >=0.8 for children aged over 8 years; 4. The spherical equivalent (SE) of binocular refraction after mydriasis was > -0.50D, and < +0.50D; 5. There were no other organic diseases affecting visual acuity in both eyes, excluding form-deprivation factors (corneal leucoma, congenital cataract, complete ptosis); 6. Informed consent, and voluntarily sign the informed consent, in line with ethical norms; Informed consent was obtained in accordance with the GCP.

Exclusion criteria

Exclusion criteria: 1. Participants with previous strabismus surgery; 2. Organic eye diseases that can cause form deprivation, such as corneal leucoma, congenital cataract, and complete ptosis; 3. Loss to follow-up due to other lesions that could reduce or complicate enrollment according to the investigator's judgment; 4. Persons with mental or legal disabilities; 5. Participants taking part in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Oxyhemoglobin;Deoxyhemoglobin;Total Oxyhemoglobin;

Secondary

MeasureTime frame
Degree of deviation;Degree of limitation of eye movement;Stereoscopic vision;Visual acuity;Ocular accommodation;Safety indicators (physical examination, vital signs, adverse events);

Countries

China

Contacts

Public ContactAiling Bi

Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine

biailing2004@hotmail.com+86 135 7316 8610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026